Atom | PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Due Dates: September 5, 2024 | January 5, 2025 | April 5, 2025 | September 5, 2025

Funding Amounts: Phase I: up to $306,872 (6 months) | Phase II: up to $2,045,816 (2 years); higher budgets possible for select topics

Summary: Supports U.S. small businesses to conduct innovative R&D aligned with NIH/CDC missions, requiring at least one clinical trial per application.

Key Information: Only applications proposing clinical trials are eligible; strict eligibility and disclosure requirements apply.

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Sign in to see full grant listing